Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Sponsors Must Notify CMS Of Part D Intentions In February

Executive Summary

Potential Medicare Rx plan sponsors will need to tell the Centers for Medicare & Medicaid Services how they intend to participate in the Part D benefit by early February

You may also be interested in...



Medicare Rx Employer Options Are Flexible But Without Windfalls, CMS Says

The Centers for Medicare & Medicaid Services is waiving several Medicare Part D plan requirements for employers to provide maximum flexibility for their participation in the drug benefit

Medco, Caremark Plan National Medicare Part D Bids; No “Fallback” In 2006

Medco and Caremark are pursuing a low-risk approach to entering the at-risk drug insurance market under Medicare Part D

Medicare Rx Employer Options Are Flexible But Without Windfalls, CMS Says

The Centers for Medicare & Medicaid Services is waiving several Medicare Part D plan requirements for employers to provide maximum flexibility for their participation in the drug benefit

Related Content

UsernamePublicRestriction

Register

OM014142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel